Invivyd insider plans sale of 39,600 shares

Invivyd, Inc. filed a Form 144 notice for a planned sale of 39,600 shares of common stock.

Rhea-AI Filing Summary

Invivyd, Inc. filed a Form 144 notice for a planned sale of 39,600 shares of common stock. The shares are to be sold through Morgan Stanley Smith Barney LLC on Nasdaq, with an aggregate market value of $61,776.00 and 281,987,033 common shares outstanding noted in the form.

The seller acquired 99,000 common shares on 02/15/2026 upon vesting of restricted stock units granted under the issuer’s 2021 Equity Incentive Plan, classified as equity compensation. The form also confirms the seller represents not knowing any undisclosed material adverse information about Invivyd.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Invivyd (IVVD) disclose in this Form 144 filing?

Invivyd’s Form 144 reports a planned sale of 39,600 common shares on Nasdaq. The filing lists $61,776.00 aggregate market value and references 281,987,033 common shares outstanding, giving investors context on the relative size of the planned sale.

How many Invivyd (IVVD) shares are planned to be sold and through which broker?

The notice covers a planned sale of 39,600 Invivyd common shares. The filing identifies Morgan Stanley Smith Barney LLC Executive Financial Services as the broker, with the shares intended to be sold on the Nasdaq stock market.

When were the Invivyd (IVVD) shares in this Form 144 acquired and how?

The seller acquired 99,000 Invivyd common shares on 02/15/2026 upon vesting of restricted stock units. These RSUs were granted under Invivyd’s 2021 Equity Incentive Plan, and the filing classifies the consideration as equity compensation rather than a cash purchase.

What is the approximate sale date and market value in Invivyd’s (IVVD) Form 144?

The Form 144 lists an approximate sale date of 02/17/2026 for the 39,600 shares. It shows an aggregate market value of $61,776.00, providing a snapshot of the transaction’s indicated size at the time of the notice.

How many Invivyd (IVVD) shares are reported as outstanding in this Form 144?

The filing notes 281,987,033 common shares outstanding for Invivyd. This figure offers a baseline against which investors can gauge the scale of the planned 39,600-share sale described in the Form 144 notice.

What representation does the seller make in Invivyd’s (IVVD) Form 144?

The seller represents that they do not know any material adverse information about Invivyd’s current or prospective operations that has not been publicly disclosed, a standard certification included when submitting a Form 144 notice of proposed sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/17/2026 - 06:32 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002025331
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Invivyd, Inc.
SEC File Number	001-40703
Address of Issuer	209 Church Street New Haven CONNECTICUT 06510
Phone	781-819-0080
Name of Person for Whose Account the Securities are To Be Sold	Lee Timothy Edward
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	39600	61776.00	281987033	02/17/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	02/15/2026	Common Stock acquired upon vesting of restricted stock units granted under the Issuer's 2021 Equity Incentive Plan	Issuer			99000	02/15/2026	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	This Form 144 reports shares to be sold to satisfy the Reporting Person's tax obligations upon vesting of a restricted stock unit award in non-discretionary "sell-to-cover" transactions pursuant to a Rule 10b5-1 plan applicable to the Reporting Person. Aggregate Market Value of the sale is based on a closing price of $1.56 for the Issuer's common stock on February 13, 2026. The actual number of shares sold will depend on the sale price of the Issuer's common stock at the time of sale.
Date of Notice	02/17/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	02/20/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jill Andersen attorney-in-fact for Timothy Edward Lee
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)